Linked Life Data

6354028

Source:http://linkedlifedata.com/resource/pubmed/id/6354028

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1983-11-23
pubmed:abstractText
In order to explore the efficacy of expiratory positive airway pressure (EPAP) in the prevention of sleep-induced respiratory abnormalities, we studied 9 patients with typical presentation of hypersomnia-sleep apnea syndrome 1 wk apart, without and with 10 cm water of EPAP. We found that EPAP significantly reduced apnea index (p less than 0.01), maximal and mean duration of apneas (p less than 0.01) and desaturation index (p less than 0.001), and significantly improved mean and minimal oxygen saturation (p less than 0.01) and awake supine arterial oxygen saturation (p less than 0.01) in all 9 patients. We also found that EPAP significantly decreased the relative time spent in Stages 1 and 2 NREM sleep (p less than 0.01) and increased the relative time spent in Stages 3 and 4 NREM sleep (p less than 0.01). These results indicate that EPAP reduces frequency and duration of apneas and the degree of nocturnal oxygen desaturation and improves sleep quality in patients with hypersomnia-sleep apnea syndrome.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0003-0805
pubmed:author
pubmed:issnType
Print
pubmed:volume
128
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
708-11
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1983
pubmed:articleTitle
Effects of expiratory positive airway pressure on sleep-induced respiratory abnormalities in patients with hypersomnia-sleep apnea syndrome.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S.